[go: up one dir, main page]

WO2011000989A1 - Organic/inorganic microporous crystalline material based on alkaline-earth cations, preparation method and uses - Google Patents

Organic/inorganic microporous crystalline material based on alkaline-earth cations, preparation method and uses Download PDF

Info

Publication number
WO2011000989A1
WO2011000989A1 PCT/ES2010/070439 ES2010070439W WO2011000989A1 WO 2011000989 A1 WO2011000989 A1 WO 2011000989A1 ES 2010070439 W ES2010070439 W ES 2010070439W WO 2011000989 A1 WO2011000989 A1 WO 2011000989A1
Authority
WO
WIPO (PCT)
Prior art keywords
value
material according
conversion
reaction mixture
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/ES2010/070439
Other languages
Spanish (es)
French (fr)
Inventor
Ana Eva Platero Prats
Enrique GUTIÉRREZ PUEBLA
Ángeles MONGE BRAVO
Natalia Snejko
Marta IGLESIAS HERNÁNDEZ
Berta GÓMEZ-LOR PÉREZ
Víctor A. DE LA PEÑA O'SHEA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consejo Superior de Investigaciones Cientificas CSIC
Fundacion Imdea Energia
Original Assignee
Consejo Superior de Investigaciones Cientificas CSIC
Fundacion Imdea Energia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior de Investigaciones Cientificas CSIC, Fundacion Imdea Energia filed Critical Consejo Superior de Investigaciones Cientificas CSIC
Publication of WO2011000989A1 publication Critical patent/WO2011000989A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/003Compounds containing elements of Groups 2 or 12 of the Periodic Table without C-Metal linkages
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/22Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
    • B01J20/26Synthetic macromolecular compounds
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D53/00Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols
    • B01D53/02Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols by adsorption, e.g. preparative gas chromatography
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/22Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/22Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
    • B01J20/223Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material containing metals, e.g. organo-metallic compounds, coordination complexes
    • B01J20/226Coordination polymers, e.g. metal-organic frameworks [MOF], zeolitic imidazolate frameworks [ZIF]
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/1691Coordination polymers, e.g. metal-organic frameworks [MOF]
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22Organic complexes
    • B01J31/2204Organic complexes the ligands containing oxygen or sulfur as complexing atoms
    • B01J31/2208Oxygen, e.g. acetylacetonates
    • B01J31/2226Anionic ligands, i.e. the overall ligand carries at least one formal negative charge
    • B01J31/223At least two oxygen atoms present in one at least bidentate or bridging ligand
    • B01J31/2239Bridging ligands, e.g. OAc in Cr2(OAc)4, Pt4(OAc)8 or dicarboxylate ligands
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/26Catalysts comprising hydrides, coordination complexes or organic compounds containing in addition, inorganic metal compounds not provided for in groups B01J31/02 - B01J31/24
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/04Calcium compounds
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2253/00Adsorbents used in seperation treatment of gases and vapours
    • B01D2253/20Organic adsorbents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/20Complexes comprising metals of Group II (IIA or IIB) as the central metal
    • B01J2531/23Calcium
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/20Complexes comprising metals of Group II (IIA or IIB) as the central metal
    • B01J2531/24Strontium

Definitions

  • the present invention relates to a family of crystalline microporous organ-inorganic materials containing alkaline earth cations and dicarboxylic acids, their preparation process and their use as reusable heterogeneous catalysts for reactions in organic chemistry, as molecular sieves and as gas absorbers and liquids
  • Nanostructured organ-inorganic hybrid materials also called MOFs (Metal-Organic Frameworks) have demonstrated their potential use as multifunctional crystalline materials with interesting properties and promising applications over the past few years.
  • MOFs Metal-Organic Frameworks
  • heterogeneous catalysts such as heterogeneous catalysts, molecular sieves, gas absorbers, LED emitters and their most recent application in controlled drug release (B. Wang et al., Nature. 2008. 453 , 207; F. Gándara et al., Cryst. Growth Des. 2008, 8, 2, 378; P. Horcajada et al., J. Am. Chem. Soc. 2008. 130, 6774).
  • MOFs Metal-Organic Frameworks
  • MOFs have been proposed as a new class of heterogeneous catalysts, due, above all, to:
  • MOFs have a good dispersion of catalytically active centers, because they are part of an organic matrix.
  • these organo-inorganic materials are proposed as potential bifunctional catalysts, taking advantage of the acid-base characteristics of the organic ligands and the reactive properties of the metals.
  • the present invention refers to an AEPF crystalline microporous organ-inorganic material, of the English Alkaline Earth Polymeric Framework (from now on material of the invention), characterized in that it presents as a repeating unit the following formula generic:
  • - M is an alkaline earth cation, in oxidation state +2,
  • - A is a host molecule, comprising a solvent selected from the list comprising ethanol, propanol, butanol, toluene, cyclohexane, hexane, heptane, octane, pyridine and any combination thereof, from the reaction medium,
  • - R is an organic group, preferably it is an aromatic group selected from phenyl, naphthyl or diphenyl, which is branched or not with other groups, that is, an isolated or several aromatic group linked together by means of an alkyl (Ci-C ⁇ ) ) linear or branched, which in turn may be substituted, preferably substituted by a halogen,
  • - x represents a value less than or equal to 4 (x ⁇ 4), preferably less than 2 (x ⁇ 2),
  • - z represents a value between O and 4, (O ⁇ z ⁇ 4) and - n is the number of host molecules and represents a value between 0 and 4 (0 ⁇ n ⁇ 4), preferably between 0 and 2 (0 ⁇ n ⁇ 2).
  • alkyl refers, in the present invention, to aliphatic, linear or branched chains, having 1 to 6 carbon atoms, for example, methyl, ethyl, n-propyl, i-propyl, n-butyl, tere-butyl, sec-butyl, n-pentyl, n-hexyl, etc.
  • the alkyl group has between 1 and 4 carbon atoms.
  • the alkyl groups may be optionally substituted by one or more substituents such as halogen, hydroxyl, azide or carboxylic acid.
  • halogen is meant, in the present invention, an atom of bromine (Br), chlorine (Cl), iodine (I) or fluorine (F), preferably fluorine (F).
  • M is selected from Mg, Ca, Sr or Ba.
  • A is a solvent selected from the list comprising ethanol, propanol, butanol, toluene, cyclohexane, hexane, heptane, octane, pyridine or any combination thereof.
  • R is represented by the general formula Ri-C (R 2 ) 2 -Ri, where Ri is an aromatic group selected from phenyl, naphthyl or diphenyl and R 2 is a group selected from methyl, ethyl, Isopropyl, terbutyl or CF3.
  • Ri is a phenyl group and R 2 is a CF3 group and, therefore, R is represented by:
  • the ratio x: y: z is 0.5: 1: 1 and n represents a value between 0 and 2 (0 ⁇ n ⁇ 2).
  • AEPF crystalline microporous organ-inorganic materials in the present invention means those nanostructured hybrid organ-inorganic materials, also called MOFs (from English, Metal-Organic Frameworks), which have demonstrated their potential use over the last few years. as multifunctional crystalline materials with interesting properties and promising applications.
  • MOFs are crystalline compounds that consist of metal ions or clusters often coordinated to rigid organic molecules to form structures of one, two or three dimensions that can be porous. In some cases, the pores are stable to the elimination of host molecules (often solvents) and can be used for the storage of gases such as hydrogen and carbon dioxide.
  • MOFs are also known as hybrid and polymer coordination matrices, although these terms are not strictly identical.
  • Scheme 1 represents in a generic way the family of carboxylic acids components of AEPF.
  • M is Ca
  • the ratio x: y: z is 0.5: 1: 1 and n is less than 1 (n ⁇ 1).
  • the organ-inorganic material of the invention is AEPF-1, and is represented by the following unit of repetition of empirical formula:
  • - A is selected from ethanol, propanol, butanol, toluene, cyclohexane, hexane, heptane, octane or any combination thereof.
  • propanol and even more preferably isopropanol.
  • the chemical composition of the organo-inorganic material of the invention is represented by the following unit of repetition of empirical formula:
  • M is Sr
  • the ratio x: y: z is 0.5: 1: 1
  • n is less than 1 (n ⁇ 1)
  • a It is pyridine.
  • the organ-inorganic material of the invention is AEPF-3, and is represented by the following unit of repetition of empirical formula:
  • - x represents a value of 0.5, - and represents a value of 1,
  • the present invention relates to a process for preparing the organ-inorganic material of the invention (from now on the method of the invention), which comprises:
  • Ri is an aromatic group selected from phenyl, naphthyl or diphenyl and R 2 is a group selected from methyl, ethyl, isopropyl, terbutyl or CF 3 , preferably in salt form,
  • a host molecule A which comprises a solvent selected from the list comprising ethanol, propanol, butanol, toluene, cyclohexane, hexane, heptane, octane, pyridine and any combination thereof, which comes from the reaction medium and
  • stage (a) heat treatment of the reaction mixture of stage (a) at a temperature between 80 ° C and 220 ° C, until its crystallization is achieved.
  • the reaction mixture has a composition, in terms of molar ratios, between the intervals:
  • the heat treatment to which the reaction mixture is subjected in step (b) is carried out at a temperature between 100 ° C and 200 ° C.
  • the heat treatment is carried out at a temperature between 130 ° C and 180 ° C. Said heat treatment can be performed in static or with agitation of the mixture. Once the crystallization is finished, the crystalline product is filtered off, washed with water and common organic solvents and air dried.
  • Another preferred embodiment of the process of the invention also includes:
  • stage (b) separation, washing and heat treatment of the crystalline product obtained in stage (b) at a temperature between 40 ° C and 150 ° C.
  • stage of separation, washing and heat treatment of the crystalline product obtained in stage (b) is carried out at a drying temperature of between 100 ° C and 120 ° C and under vacuum for a time between 10 and 2O h.
  • Thermogravimetry analysis determines the content (n) of A when the material is heated at temperatures up to 150 ° C in an inert atmosphere of N 2 .
  • the IR spectroscopy technique allows the characterization of these materials.
  • the IR spectra of these materials can be recorded in the transmission mode by preparing wafers of these solids that are transparent to infrared radiation by compression at pressures between 1 and 10 Tm x cm 2 for a time between 1 and 5 min.
  • X-ray diffraction demonstrates the purity and crystallinity of the material.
  • the present invention refers to the use of the organ-inorganic material of the invention as a catalyst in a process of conversion of compounds, which comprises contacting a feed of compounds, as substrates, with an amount of the material of the invention and other reactive compounds.
  • the compound conversion process is a hydrogenation of alkenes using H 2 as a reducing agent. (Scheme 3).
  • R, R ', R ", R'” represent alkyl or aryl groups.
  • the compound conversion process is a hydroformylation of alkenes. (Scheme 4).
  • R represents an alkyl or aryl group
  • the compound conversion process is a hydrosilylation of aldehydes using as a reagent an organic compound derived from silane. (Scheme 5).
  • R, R ', R ", Ri represent alkyl or aryl groups.
  • the compound conversion process is a hydrosilylation of ketones using as a reagent an organic compound derived from the silane. (Scheme 6).
  • R, R ', R ", Ri, R2 represent alkyl or aryl groups.
  • the compound conversion process is a hydrosilylation of alkenes using as a reagent an organic compound derived from the silane. (Scheme 7).
  • R, R ', R ", Ri, R 2 represent alkyl or aryl groups.
  • the compound conversion process is an intermolecular hydroamination of linear aminoalkenes.
  • Ri represents an alkyl group
  • the present invention refers to the use of the organo-inorganic material of the invention as a selective absorbent component of compounds, which comprises contacting a feed of a mixture of compounds, including isomers, with an amount of the material of the invention .
  • the present invention refers to the use of the organo-inorganic material of the invention as a selective molecular sieve, which comprises contacting a feed of a mixture of compounds, including isomers, with an amount of the material of the invention passing through said material only those molecules that by their shape and / or size can do so, retaining the others.
  • the present invention refers to the use of the organo-inorganic material of the invention as a controlled drug delivery system.
  • Fig. 1 Shows the powder X-ray diffraction pattern for the AEPF-1 compound.
  • Fig. 2. Shows the powder X-ray diffraction pattern for the AEPF-2 compound.
  • Fig. 3. Shows the powder X-ray diffraction pattern for the AEPF-3 compound.
  • Fig. 4. Shows the structural view of the AEPF-1 compound. The molecules of the host organic compound have been removed from the figure for greater understanding of the structure.
  • Example 1 Synthesis of AEFP-1 A solution of H 2 L (400 mg, 1 mmol) in 9 ml of isopropanol (Propan-2-ol, CH 3 CH (OH) CH 3 ) is mixed with another solution of Ca ( CH 3 CO 2 ) 2 -4 H 2 O (178 mg, 1 mmol) in 10 ml of distilled water, under continuous and vigorous stirring. The resulting dispersion is heated at 170 ° C, under autogenous system pressure, for 72 h. Then, the mixture is rapidly cooled to room temperature. The product is filtered and washed successively with distilled water and acetone.
  • Scheme 2 depicts the carboxylic acid component of AEPF-1, referred to as H 2 L from now on.
  • AEPF-1 the X-ray diffraction pattern of [Ca (C 25 5 F 9 O 6 Hi 5 ) 0.7C 3 H 7 O] as synthesized, obtained by the powder method using a divergence slit Fixed, with a Bruker Advance equipment equipped with copper anti-cathode, it is characterized by the angular values, the corresponding inter-planar spacings (d) and the relative intensities (1/10) shown in Table 2 and in Figure 1.
  • Table 2 and in Figure 1.
  • An estimated 0.3 ° discrepancy depending on the alignment of the equipment, the crystallinity of the sample and degree of purity.
  • AEPF-2 the X-ray diffraction pattern of [Ca (C255F 9 ⁇ 6Hi 5 )] as synthesized, obtained by the powder method using a fixed divergence slit, with a Bruker Advance equipment equipped with an anti-cathode of copper, is characterized by angular values, corresponding inter-planar spacings (d) and relative intensities (1/10) shown in Table 3 and Figure 2.
  • d inter-planar spacings
  • Table 3 and Figure 2 A discrepancy of 0.3 ° is estimated, depending on the alignment of the equipment , The crystallinity of the sample and degree of purity.
  • the spatial group and cell parameters of the AEPF-2 material have been determined by X-ray diffraction of the polycrystalline sample.
  • Hydrogenation of styrene (vinylbenzene, CsH 8 ) with H 2 (Scheme 7) is achieved with 100% selectivity and 100% alkene conversion by treating a mixture of alkene dissolved in toluene with a pressure of H 2 of 5 atm, in the presence of the catalyst of Example 1 in a catalyst / alkene ratio of 1 mol%.
  • the reaction temperature can vary between room temperature and 100 ° C, achieving an optimum speed at 70 ° C.
  • Hydrosilylation of acetophenone with diphenylsilane achieves 100% selectivity and conversion of acetophenone greater than 70% by treating a mixture of ketone and silane in a ratio of 1: 2 dissolved in dry toluene at 90 ° C, in the presence of the catalyst of Example 1 in a catalyst / acetone ratio of 10 mol%.
  • Hydrosilylation of styrene with diphenylsilane achieves 100% selectivity to the linear product and conversion of 100% alkene by treating a mixture of alkene and silane in a 3: 1 ratio dissolved in dry toluene at 90 ° C, in the presence of the catalyst of Example 1 in a catalyst / alkene ratio of 10 mol%.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)

Abstract

The present invention relates to a family of organic/inorganic microporous crystalline materials containing alkaline-earth cations and dicarboxylic acids, the method for preparation thereof and the use thereof as reusable heterogeneous catalysts for reactions in organic chemistry, as molecular sieves and as gas and liquid absorbents.

Description

MATERIAL ÓRGANO-INORGÁNICO MICROPOROSO CRISTALINO BASADO EN CATIONES ALCALINOTÉRREOS, PROCEDIMIENTO DE  ORGANIC-INORGANIC MICROPOROUS CRYSTAL MATERIAL BASED ON ALKALINOTERAL CATIONS, PROCEDURE FOR

PREPARACIÓN Y USOS La presente invención se refiere a una familia de materiales órgano-inorgánicos microporosos cristalinos conteniendo cationes alcalinotérreos y ácidos dicarboxílicos, su procedimiento de preparación y su uso como catalizadores heterogéneos reutilizables para reacciones en química orgánica, como tamices moleculares y como absorbentes de gases y líquidos.  PREPARATION AND USES The present invention relates to a family of crystalline microporous organ-inorganic materials containing alkaline earth cations and dicarboxylic acids, their preparation process and their use as reusable heterogeneous catalysts for reactions in organic chemistry, as molecular sieves and as gas absorbers and liquids

ESTADO DE LA TÉCNICA STATE OF THE TECHNIQUE

Los materiales híbridos órgano-inorgánicos nanoestructurados, también llamados MOFs (del inglés, Metal-Organic Frameworks), han demostrado durante el transcurso de los últimos años su potencial uso como materiales cristalinos multifuncionales con interesantes propiedades y prometedoras aplicaciones. A modo de ejemplo, cabe destacar el uso de este tipo de materiales como catalizadores heterogéneos, tamices moleculares, absorbentes de gases, emisores LEDs y su más reciente aplicación en liberación controlada de fármacos (B. Wang y col., Nature. 2008. 453, 207; F. Gándara y col., Cryst. Growth Des. 2008, 8, 2, 378; P. Horcajada y col., J. Am. Chem. Soc. 2008. 130, 6774). Actualmente, muchos grupos de investigación están intentando preparar MOFs con nuevas estructuras y composición que den lugar a Ia mejora sustancial de las propiedades de estos sistemas. Nanostructured organ-inorganic hybrid materials, also called MOFs (Metal-Organic Frameworks), have demonstrated their potential use as multifunctional crystalline materials with interesting properties and promising applications over the past few years. As an example, it is worth mentioning the use of such materials as heterogeneous catalysts, molecular sieves, gas absorbers, LED emitters and their most recent application in controlled drug release (B. Wang et al., Nature. 2008. 453 , 207; F. Gándara et al., Cryst. Growth Des. 2008, 8, 2, 378; P. Horcajada et al., J. Am. Chem. Soc. 2008. 130, 6774). Currently, many research groups are trying to prepare MOFs with new structures and composition that lead to the substantial improvement of the properties of these systems.

Durante los últimos años, el uso de cationes divalentes y trivalentes derivados de metales de transición y, más recientemente, de tierras raras, ha dado lugar a Ia preparación de una gran variedad de esta familia de materiales cristalinos microporosos. Sin embargo, si extendemos nuestra búsqueda a MOFs basados en cationes alcalinotérreos encontramos pocos ejemplos reportados (R. K. B. Nielsen y col., Solid State Science. 2006, 8, 1237; C. Vo Ikringer y col., Solid State Science. 2007, 9, 455 ; C. Volkringer y col., Cryst. Growth Des. 2008, 8, 658; S. Chen y col., Anorg. AIIg. Chem. 2008. 634, 1591 ; C. A. Williams y col., Cryst. Growth Des. 2008, 8(3), 911 ), a pesar de las interesantes propiedades de sorción (O2, H2, CO2) (M. Dinca y col., J. Am. Chem. Soc. 2005, 127, 9376) y comportamiento catalítico (J. Spielmann y col., Angew. Chem. Int. Ed. 2008, 47, 9434) que ofrecen estos elementos. During the last years, the use of divalent and trivalent cations derived from transition metals and, more recently, from rare earths, has resulted in the preparation of a great variety of this family of microporous crystalline materials. However, if we extend our search to MOFs based on alkaline earth cations, we find few reported examples (RKB Nielsen et al., Solid State Science. 2006, 8, 1237; C. Vo Ikringer et al., Solid State Science. 2007, 9, 455; C. Volkringer et al., Cryst. Growth Des. 2008, 8, 658; S. Chen et al., Anorg. AIIg. Chem. 2008. 634, 1591; CA Williams et al., Cryst. Growth Des. 2008, 8 (3), 911), despite the interesting properties of sorption (O 2 , H 2 , CO 2 ) (M. Dinca et al., J. Am. Chem. Soc. 2005, 127, 9376) and catalytic behavior (J. Spielmann et al., Angew. Chem. Int. Ed. 2008, 47, 9434) that offer these elements.

Más concretamente, cabe destacar que los MOFs se han propuesto como una nueva clase de catalizadores heterogéneos, debido, sobre todo, a: More specifically, it should be noted that MOFs have been proposed as a new class of heterogeneous catalysts, due, above all, to:

- En primer lugar, los MOFs presentan una buena dispersión de los centros catalíticamente activos, debido a que éstos se hallan formando parte de una matriz orgánica.  - First, MOFs have a good dispersion of catalytically active centers, because they are part of an organic matrix.

- En segundo lugar, una gran cantidad de estos compuestos presentan micro o mesoporisidad, Io que no sólo favorece Ia actividad catalítica sino también tiene una influencia muy notable en Ia selectividad.  - Secondly, a large number of these compounds have micro or mesoporism, which not only favors the catalytic activity but also has a very significant influence on the selectivity.

- Además, debido a Ia naturaleza híbrida de estos materiales órgano- inorgánicos, éstos se proponen como potenciales catalizadores bifuncionales, aprovechando las características ácido-base de los ligandos orgánicos y las propiedades reactivas de los metales.  - In addition, due to the hybrid nature of these organo-inorganic materials, these are proposed as potential bifunctional catalysts, taking advantage of the acid-base characteristics of the organic ligands and the reactive properties of the metals.

- Por otro lado, este tipo de compuestos están principalmente indicados para reacciones en química fina y obtención de productos de alto valor añadido, ya que éstas se llevan a cabo en condiciones suaves.  - On the other hand, these types of compounds are mainly indicated for reactions in fine chemistry and obtaining products with high added value, since these are carried out under mild conditions.

Por tanto, y tal y como se mostrará a Io largo de Ia memoria, el diseño de sistemas tipo MOFs basados en cationes alcalinotérreos y que posean propiedades catalíticas y de sorción se presenta como una alternativa de bajo coste y, sobre todo, de un menor impacto medioambiental, en comparación con los sistemas utilizados actualmente a nivel industrial. En Ia Tabla 1 se muestran los metales en los que están basados catalizadores comúnmente usados, para alguna de las reacciones más demandadas a nivel industrial. Therefore, and as will be shown throughout the report, the design of MOFs-type systems based on alkaline earth cations and possessing catalytic and sorption properties is presented as a low-cost alternative and, above all, a lower environmental impact, compared to the systems currently used at industrial level. Table 1 shows the metals on which commonly used catalysts are based, for some of the most demanded reactions at the industrial level.

Tabla 1

Figure imgf000004_0001
Entre los más importantes, Ia industria petroquímica utiliza anualmente grandes cantidades de metales preciosos soportados en diversos materiales porosos, como sílice o sales inorgánicas divididas (CaCOs), como catalizador de reacciones de hidrogenación, especialmente de olefinas. DESCRIPCIÓN DE LA INVENCIÓN Table 1
Figure imgf000004_0001
Among the most important, the petrochemical industry annually uses large amounts of precious metals supported in various porous materials, such as silica or divided inorganic salts (CaCOs), as a catalyst for hydrogenation reactions, especially olefins. DESCRIPTION OF THE INVENTION

Por tanto, en un primer aspecto, Ia presente invención se refiere a un material órgano-inorgánico microporoso cristalino AEPF, del inglés Alkaline Earth Polymeric Framework (a partir de ahora material de Ia invención), caracterizado porque presenta como unidad de repetición Ia siguiente fórmula genérica: Therefore, in a first aspect, the present invention refers to an AEPF crystalline microporous organ-inorganic material, of the English Alkaline Earth Polymeric Framework (from now on material of the invention), characterized in that it presents as a repeating unit the following formula generic:

[M (HOOC-R-COOH)x (OOC-R-COO)y (H2O)2 nA] donde: [M (HOOC-R-COOH) x (OOC-R-COO) and (H 2 O) 2 nA] where:

- M es un catión alcalinotérreo, en estado de oxidación +2,  - M is an alkaline earth cation, in oxidation state +2,

- A es una molécula huésped, que comprende un solvente seleccionado de Ia lista que comprende etanol, propanol, butanol, tolueno, ciclohexano, hexano, heptano, octano, piridina y cualquiera de sus combinaciones, procedente del medio de reacción,  - A is a host molecule, comprising a solvent selected from the list comprising ethanol, propanol, butanol, toluene, cyclohexane, hexane, heptane, octane, pyridine and any combination thereof, from the reaction medium,

- R es un grupo orgánico, preferiblemente es un grupo aromático seleccionado entre fenilo, naftilo o difenilo, que está ramificado o no con otros grupos, es decir, un grupo aromático aislado o varios unidos entre sí por medio de un alquilo (Ci-Cβ) lineal o ramificado, que a su vez puede estar sustituido, preferiblemente sustituido por un halógeno, - R is an organic group, preferably it is an aromatic group selected from phenyl, naphthyl or diphenyl, which is branched or not with other groups, that is, an isolated or several aromatic group linked together by means of an alkyl (Ci-Cβ) ) linear or branched, which in turn may be substituted, preferably substituted by a halogen,

- x representa un valor menor o igual a 4 (x < 4), preferiblemente inferior a 2 (x < 2), - x represents a value less than or equal to 4 (x <4), preferably less than 2 (x <2),

- y representa un valor de entre 0,5 y 2, (0,5≤ y≤2),  - and represents a value between 0.5 and 2, (0.5≤ and ≤2),

- z representa un valor de entre O y 4, (O < z <4) y - n es el número de moléculas huésped y representa un valor entre 0 y 4 (0 < n <4), preferiblemente entre 0 y 2 (0 < n <2). - z represents a value between O and 4, (O <z <4) and - n is the number of host molecules and represents a value between 0 and 4 (0 <n <4), preferably between 0 and 2 (0 <n <2).

El término "alquilo" se refiere, en Ia presente invención, a cadenas alifáticas, lineales o ramificadas, que tienen de 1 a 6 átomos de carbono, por ejemplo, metilo, etilo, n-propilo, i-propilo, n-butilo, tere-butilo, sec-butilo, n-pentilo, n- hexilo, etc. Preferiblemente, el grupo alquilo tiene entre 1 y 4 átomos de carbono. Los grupos alquilo pueden estar opcionalmente sustituidos por uno o más sustituyentes tales como halógeno, hidroxilo, azida o ácido carboxílico. The term "alkyl" refers, in the present invention, to aliphatic, linear or branched chains, having 1 to 6 carbon atoms, for example, methyl, ethyl, n-propyl, i-propyl, n-butyl, tere-butyl, sec-butyl, n-pentyl, n-hexyl, etc. Preferably, the alkyl group has between 1 and 4 carbon atoms. The alkyl groups may be optionally substituted by one or more substituents such as halogen, hydroxyl, azide or carboxylic acid.

Por "halógeno" se entiende, en Ia presente invención, un átomo de bromo (Br), cloro (Cl), yodo (I) o flúor (F), preferiblemente flúor (F). By "halogen" is meant, in the present invention, an atom of bromine (Br), chlorine (Cl), iodine (I) or fluorine (F), preferably fluorine (F).

En una realización preferida, M se selecciona entre Mg, Ca, Sr o Ba. In a preferred embodiment, M is selected from Mg, Ca, Sr or Ba.

En otra realización preferida, A es un solvente seleccionado de Ia lista que comprende etanol, propanol, butanol, tolueno, ciclohexano, hexano, heptano, octano, piridina o cualquiera de sus combinaciones. En otra realización preferida, R se representa por Ia fórmula general Ri-C(R2)2- Ri, donde Ri es un grupo aromático seleccionado de entre fenilo, naftilo o difenilo y R2 es un grupo seleccionado de entre metilo, etilo, isopropilo, terbutilo o CF3. Preferiblemente, Ri es un grupo fenilo y R2 es un grupo CF3 y, por tanto, R se representa por: In another preferred embodiment, A is a solvent selected from the list comprising ethanol, propanol, butanol, toluene, cyclohexane, hexane, heptane, octane, pyridine or any combination thereof. In another preferred embodiment, R is represented by the general formula Ri-C (R 2 ) 2 -Ri, where Ri is an aromatic group selected from phenyl, naphthyl or diphenyl and R 2 is a group selected from methyl, ethyl, Isopropyl, terbutyl or CF3. Preferably, Ri is a phenyl group and R 2 is a CF3 group and, therefore, R is represented by:

Figure imgf000005_0001
Figure imgf000005_0001

En otra realización preferida, Ia relación x:y:z es 0,5:1 :1 y n representa un valor entre 0 y 2 (0 < n <2). Por "materiales órgano-inorgánicos microporosos cristalinos AEPF" en Ia presente invención se entiende aquellos materiales híbridos órgano-inorgánicos nanoestructurados, también llamados MOFs (del inglés, Metal-Organic Frameworks), que han demostrado durante el transcurso de los últimos años su potencial uso como materiales cristalinos multifuncionales con interesantes propiedades y prometedoras aplicaciones. Estos MOFsson compuestos cristalinos que consisten en iones metálicos o racimos coordinados a menudo a moléculas orgánicas rígidas para formar estructuras de una, dos o tres dimensiones que pueden ser porosas. En algunos casos, los poros son estables a Ia eliminación de las moléculas huésped (a menudo disolventes) y pueden ser utilizados para el almacenamiento de gases como el hidrógeno y el dióxido de carbono. Los MOFs también son conocidos como matrices híbridas y de coordinación de polímeros, aunque estos términos no son estrictamente idénticos. In another preferred embodiment, the ratio x: y: z is 0.5: 1: 1 and n represents a value between 0 and 2 (0 <n <2). "AEPF crystalline microporous organ-inorganic materials" in the present invention means those nanostructured hybrid organ-inorganic materials, also called MOFs (from English, Metal-Organic Frameworks), which have demonstrated their potential use over the last few years. as multifunctional crystalline materials with interesting properties and promising applications. These MOFs are crystalline compounds that consist of metal ions or clusters often coordinated to rigid organic molecules to form structures of one, two or three dimensions that can be porous. In some cases, the pores are stable to the elimination of host molecules (often solvents) and can be used for the storage of gases such as hydrogen and carbon dioxide. MOFs are also known as hybrid and polymer coordination matrices, although these terms are not strictly identical.

En el Esquema 1 se representa de forma genérica Ia familia de ácidos carboxílicos componentes de AEPF. Scheme 1 represents in a generic way the family of carboxylic acids components of AEPF.

HOOC R COOH HOOC R COOH

Esquema 1  Scheme 1

En el Esquema 2 se representa una realización preferida de Ia familia de ácidos carboxílicos componentes de AEPF, donde R es un difenilo como se ha descrito anteriormente: In Scheme 2 a preferred embodiment of the family of carboxylic acids components of AEPF is represented, where R is a diphenyl as described above:

Figure imgf000006_0001
Figure imgf000006_0001

Esquema 2 En una realización preferida, en Ia composición química del material órgano- inorgánico de Ia invención, M es Ca, Ia relación x:y:z es 0,5:1 :1 y n es menor que 1 (n < 1 ). Más preferiblemente, el material órgano-inorgánico de Ia invención es AEPF-1 , y se representa por Ia siguiente unidad de repetición de fórmula empírica: Scheme 2 In a preferred embodiment, in the chemical composition of the organo-inorganic material of the invention, M is Ca, the ratio x: y: z is 0.5: 1: 1 and n is less than 1 (n <1). More preferably, the organ-inorganic material of the invention is AEPF-1, and is represented by the following unit of repetition of empirical formula:

[Ca (Ci7H10O4F6)X (Ci7H8O4F6)y (H2O)z-nA] [Ca (Ci 7 H 10 O 4 F 6 ) X (Ci 7 H 8 O 4 F 6 ) and (H 2 O) z -nA]

donde:  where:

- x representa un valor de 0,5,  - x represents a value of 0.5,

- y representa un valor de 1 ,  - and represents a value of 1,

- z representa un valor de 1 ,  - z represents a value of 1,

- n representa un valor de 0,7 y  - n represents a value of 0.7 and

- A se selecciona de entre etanol, propanol, butanol, tolueno, ciclohexano, hexano, heptano, octano o cualquiera de sus combinaciones. Preferiblemente propanol, y aún más preferiblemente isopropanol.  - A is selected from ethanol, propanol, butanol, toluene, cyclohexane, hexane, heptane, octane or any combination thereof. Preferably propanol, and even more preferably isopropanol.

En otra realización más preferida, Ia composición química del material órgano- inorgánico de Ia invención, AEPF-2, se representa por Ia siguiente unidad de repetición de fórmula empírica: In another more preferred embodiment, the chemical composition of the organo-inorganic material of the invention, AEPF-2, is represented by the following unit of repetition of empirical formula:

[Ca (Ci7HioO4F6)x (Ci7H8O4F6)y (H2O)Z] donde: [Ca (Ci 7 HioO 4 F 6 ) x (Ci 7 H 8 O 4 F 6 ) and (H 2 O) Z ] where:

- x representa un valor de 0,5,  - x represents a value of 0.5,

- y representa un valor de 1 ,  - and represents a value of 1,

- z representa un valor de 1 ,  - z represents a value of 1,

- n representa un valor de 0.  - n represents a value of 0.

En otra realización preferida, en Ia composición química del material órgano- inorgánico de Ia invención, M es Sr, Ia relación x:y:z es 0,5:1 :1 , n es menor que 1 (n < 1 ) y A es piridina. Más preferiblemente, el material órgano-inorgánico de Ia invención es AEPF-3, y se representa por Ia siguiente unidad de repetición de fórmula empírica: In another preferred embodiment, in the chemical composition of the organo-inorganic material of the invention, M is Sr, the ratio x: y: z is 0.5: 1: 1, n is less than 1 (n <1) and A It is pyridine. More preferably, the organ-inorganic material of the invention is AEPF-3, and is represented by the following unit of repetition of empirical formula:

[Sr (Ci7H10O4F6)X (Ci7H8O4F6)y (H2O^nC5H5N] donde: [Sr (Ci 7 H 10 O 4 F 6 ) X (Ci 7 H 8 O 4 F 6 ) and (H 2 O ^ nC 5 H 5 N] where:

- x representa un valor de 0,5, - y representa un valor de 1 , - x represents a value of 0.5, - and represents a value of 1,

- z representa un valor de 1 ,  - z represents a value of 1,

- n representa un valor entre 0 y 1 (0 < n≤ 1 ). En un segundo aspecto, Ia presente invención se refiere a un procedimiento de preparación del material órgano-inorgánico de Ia invención (a partir de ahora procedimiento de Ia invención), que comprende:  - n represents a value between 0 and 1 (0 <n≤ 1). In a second aspect, the present invention relates to a process for preparing the organ-inorganic material of the invention (from now on the method of the invention), which comprises:

a) preparación de una mezcla de reacción que comprende:  a) preparation of a reaction mixture comprising:

un catión alcalinotérreo M,  an alkaline earth cation M,

- un ácido dicarboxílico HOOC-RrC(R2)2-Ri-COOH, donde Ri es un grupo aromático seleccionado de entre fenilo, naftilo o difenilo y R2 es un grupo seleccionado de entre metilo, etilo, isopropilo, terbutilo o CF3, preferiblemente en forma de sal,- a HOOC-R r C (R 2 ) 2 -Ri-COOH dicarboxylic acid, where Ri is an aromatic group selected from phenyl, naphthyl or diphenyl and R 2 is a group selected from methyl, ethyl, isopropyl, terbutyl or CF 3 , preferably in salt form,

- una molécula huésped A, que comprende un solvente seleccionado de Ia lista que comprende etanol, propanol, butanol, tolueno, ciclohexano, hexano, heptano, octano, piridina y cualquiera de sus combinaciones, que procede del medio de reacción y - a host molecule A, which comprises a solvent selected from the list comprising ethanol, propanol, butanol, toluene, cyclohexane, hexane, heptane, octane, pyridine and any combination thereof, which comes from the reaction medium and

- agua;  - Water;

b) tratamiento térmico de Ia mezcla de reacción de Ia etapa (a) a una temperatura de entre 80° C y 220° C, hasta conseguir su cristalización.  b) heat treatment of the reaction mixture of stage (a) at a temperature between 80 ° C and 220 ° C, until its crystallization is achieved.

En una realización preferida del procedimiento de Ia invención, Ia mezcla de reacción tiene una composición, en términos de relaciones molares, comprendida entre los intervalos: In a preferred embodiment of the process of the invention, the reaction mixture has a composition, in terms of molar ratios, between the intervals:

- M/ácido dicarboxílico = 0,25-1  - M / dicarboxylic acid = 0.25-1

- H2O/S = 4,5-10,3 - H 2 O / S = 4.5-10.3

- H2O/M = 300-800 - H 2 O / M = 300-800

En otra realización preferida del procedimiento de Ia invención, el tratamiento térmico al que se somete Ia mezcla de reacción en Ia etapa (b) se realiza a una temperatura de entre 100° C y 200° C. Preferiblemente, el tratamiento térmico se realiza a una temperatura de entre 130° C y 180° C. Dicho tratamiento térmico puede realizarse en estático o con agitación de Ia mezcla. Una vez finalizada Ia cristalización, el producto cristalino se separa por filtración, se lava con agua y disolventes orgánicos comunes y se seca al aire. In another preferred embodiment of the process of the invention, the heat treatment to which the reaction mixture is subjected in step (b) is carried out at a temperature between 100 ° C and 200 ° C. Preferably, the heat treatment is carried out at a temperature between 130 ° C and 180 ° C. Said heat treatment can be performed in static or with agitation of the mixture. Once the crystallization is finished, the crystalline product is filtered off, washed with water and common organic solvents and air dried.

Por ello, otra realización preferida del procedimiento de Ia invención, además comprende: Therefore, another preferred embodiment of the process of the invention also includes:

c) separación, lavado y tratamiento térmico del producto cristalino obtenido en Ia etapa (b) a una temperatura entre 40° C y 150° C.  c) separation, washing and heat treatment of the crystalline product obtained in stage (b) at a temperature between 40 ° C and 150 ° C.

Más preferiblemente, Ia etapa de separación, lavado y tratamiento térmico del producto cristalino obtenido en Ia etapa (b) se lleva a cabo a una temperatura de secado de entre 100° C y 120° C y a vacío durante un tiempo de entre 10 y 2O h. More preferably, the stage of separation, washing and heat treatment of the crystalline product obtained in stage (b) is carried out at a drying temperature of between 100 ° C and 120 ° C and under vacuum for a time between 10 and 2O h.

El análisis por termogravimetría determina el contenido (n) de A cuando el material se calienta a temperaturas de hasta 150° C en atmósfera inerte de N2. Thermogravimetry analysis determines the content (n) of A when the material is heated at temperatures up to 150 ° C in an inert atmosphere of N 2 .

La técnica de espectroscopia IR permite Ia caracterización de estos materiales. Así, los espectros de IR de estos materiales pueden registrarse en el modo de transmisión preparando obleas de estos sólidos que sean transparente a Ia radiación infrarroja mediante compresión a presiones entre 1 y 10 Tm x cm2 durante un tiempo entre 1 y 5 min. The IR spectroscopy technique allows the characterization of these materials. Thus, the IR spectra of these materials can be recorded in the transmission mode by preparing wafers of these solids that are transparent to infrared radiation by compression at pressures between 1 and 10 Tm x cm 2 for a time between 1 and 5 min.

La difracción de rayos X demuestra Ia pureza y cristalinidad del material. X-ray diffraction demonstrates the purity and crystallinity of the material.

El área superficial de estos materiales se puede determinar mediante isotermas de adsorción de gases (N2 y Ar) aplicando algoritmos Langmuir. En un último aspecto, Ia presente invención se refiere al uso del material órgano-inorgánico de Ia invención como catalizador en un proceso de conversión de compuestos, que comprende poner en contacto una alimentación de compuestos, como substratos, con una cantidad del material de Ia invención y de otros compuestos reactivos. The surface area of these materials can be determined by gas adsorption isotherms (N 2 and Ar) by applying Langmuir algorithms. In a final aspect, the present invention refers to the use of the organ-inorganic material of the invention as a catalyst in a process of conversion of compounds, which comprises contacting a feed of compounds, as substrates, with an amount of the material of the invention and other reactive compounds.

En una realización más preferida, el proceso de conversión de compuestos es una hidrogenación de alquenos usando como agente reductor H2. (Esquema 3). In a more preferred embodiment, the compound conversion process is a hydrogenation of alkenes using H 2 as a reducing agent. (Scheme 3).

Figure imgf000010_0001
Figure imgf000010_0001

Esquema 3  Scheme 3

Donde R, R', R", R'" representan grupos alquilo o arílo.  Where R, R ', R ", R'" represent alkyl or aryl groups.

En otra realización más preferida, el proceso de conversión de compuestos es una hidroformilación de alquenos. (Esquema 4). In another more preferred embodiment, the compound conversion process is a hydroformylation of alkenes. (Scheme 4).

Figure imgf000010_0002
Figure imgf000010_0002

Esquema 4  Scheme 4

Donde R representan un grupo alquilo o arílo  Where R represents an alkyl or aryl group

En otra realización más preferida, el proceso de conversión de compuestos es una hidrosililación de aldehidos usando como reactivo un compuesto orgánico derivado del silano. (Esquema 5).

Figure imgf000011_0001
In another more preferred embodiment, the compound conversion process is a hydrosilylation of aldehydes using as a reagent an organic compound derived from silane. (Scheme 5).
Figure imgf000011_0001

Esquema 5  Scheme 5

Donde R, R', R", Ri representan grupos alquilo o arilo.  Where R, R ', R ", Ri represent alkyl or aryl groups.

En otra realización más preferida, el proceso de conversión de compuestos es una hidrosililación de cetonas usando como reactivo un compuesto orgánico derivado del silano. (Esquema 6). In another more preferred embodiment, the compound conversion process is a hydrosilylation of ketones using as a reagent an organic compound derived from the silane. (Scheme 6).

Figure imgf000011_0002
Figure imgf000011_0002

Esquema 6 Scheme 6

Donde R, R', R", Ri, R2 representan grupos alquilo o arilo.  Where R, R ', R ", Ri, R2 represent alkyl or aryl groups.

En otra realización más preferida, el proceso de conversión de compuestos es una hidrosililación de alquenos usando como reactivo un compuesto orgánico derivado del silano. (Esquema 7). In another more preferred embodiment, the compound conversion process is a hydrosilylation of alkenes using as a reagent an organic compound derived from the silane. (Scheme 7).

Figure imgf000011_0003
Figure imgf000011_0003

Esquema 7  Scheme 7

Donde R, R', R", Ri, R2 representan grupos alquilo o arilo. En otra realización más preferida, el proceso de conversión de compuestos es una hidroaminación intermolecular de aminoalquenos lineales. Where R, R ', R ", Ri, R 2 represent alkyl or aryl groups. In another more preferred embodiment, the compound conversion process is an intermolecular hydroamination of linear aminoalkenes.

Figure imgf000012_0001
Esquema 8
Figure imgf000012_0001
Scheme 8

donde Ri representa un grupo alquilo.  where Ri represents an alkyl group.

En otro aspecto, Ia presente invención se refiere al uso del material órgano- inorgánico de Ia invención como componente absorbente selectivo de compuestos, que comprende poner en contacto una alimentación de una mezcla de compuestos, incluidos isómeros, con una cantidad del material de Ia invención. In another aspect, the present invention refers to the use of the organo-inorganic material of the invention as a selective absorbent component of compounds, which comprises contacting a feed of a mixture of compounds, including isomers, with an amount of the material of the invention .

En otro aspecto, Ia presente invención se refiere al uso del material organo- inorgánico de Ia invención como tamiz molecular selectivo, que comprende poner en contacto una alimentación de una mezcla de compuestos, incluidos de isómeros, con una cantidad del material de Ia invención pasando a través de dicho material sólo aquellas moléculas que por su forma y/o tamaño puedan hacerlo, reteniendo a las demás. In another aspect, the present invention refers to the use of the organo-inorganic material of the invention as a selective molecular sieve, which comprises contacting a feed of a mixture of compounds, including isomers, with an amount of the material of the invention passing through said material only those molecules that by their shape and / or size can do so, retaining the others.

En otro aspecto, Ia presente invención se refiere al uso del material órgano- inorgánico de Ia invención como sistema de liberación controlada de fármacos. In another aspect, the present invention refers to the use of the organo-inorganic material of the invention as a controlled drug delivery system.

Los expertos en Ia materia valorarán que Ia presente invención pueda realizarse dentro de un amplio margen de parámetros, concentraciones y condiciones equivalentes sin alejarse del espíritu y del alcance de Ia invención y sin experimentaciones indebidas. Si bien esta invención se ha descrito en relación con dichos modos de realización, se entiende que puede ser objeto de modificaciones adicionales. Este documento pretende abarcar cualquier variante, uso o adaptación de Ia invención siguiendo los principios generales de Ia misma e incluyendo las variantes procedentes de Ia presente divulgación, tal como Io disponen las prácticas conocidas o consuetudinarias del sector técnico al cual pertenece Ia invención. DESCRIPCIÓN DE LAS FIGURAS Those skilled in the art will assess that the present invention can be carried out within a wide range of parameters, concentrations and equivalent conditions without departing from the spirit and scope of the invention and without undue experimentation. While this invention has been described in relation to said embodiments, it is understood that it may be subject to further modifications. This document is intended to cover any variant, use or adaptation of the invention following the general principles of The same and including the variants coming from the present disclosure, such as the known or customary practices of the technical sector to which the invention belongs. DESCRIPTION OF THE FIGURES

Fig. 1. Muestra el patrón de difracción de rayos X en polvo para el compuesto AEPF-1. Fig. 2. Muestra el patrón de difracción de rayos X en polvo para el compuesto AEPF-2. Fig. 1. Shows the powder X-ray diffraction pattern for the AEPF-1 compound. Fig. 2. Shows the powder X-ray diffraction pattern for the AEPF-2 compound.

Fig. 3. Muestra el patrón de difracción de rayos X en polvo para el compuesto AEPF-3. Fig. 3. Shows the powder X-ray diffraction pattern for the AEPF-3 compound.

Fig. 4. Muestra Ia vista estructural del compuesto AEPF-1. Las moléculas del compuesto orgánico huésped han sido eliminadas de Ia figura para Ia mayor comprensión de Ia estructura. EJEMPLOS Fig. 4. Shows the structural view of the AEPF-1 compound. The molecules of the host organic compound have been removed from the figure for greater understanding of the structure. EXAMPLES

Los siguientes ejemplos se presentan como guía adicional para el experto medio en Ia materia y en ningún caso deben considerarse como una limitación de Ia invención. Estos ensayos realizados por los inventores ponen de manifiesto Ia especificidad y efectividad del material órgano-inorgánico microporoso cristalino AEPF objeto de Ia presente invención. The following examples are presented as an additional guide for the average expert in the field and in no case should they be considered as a limitation of the invention. These tests carried out by the inventors show the specificity and effectiveness of the microporous crystalline organ-inorganic AEPF material object of the present invention.

Ejemplo 1. Síntesis de AEFP-1 Se mezclan una disolución de H2L (400 mg, 1 mmol) en 9 mi de isopropanol (Propan-2-ol, CH3CH(OH)CH3) con otra disolución de Ca(CH3CO2)2-4 H2O (178 mg, 1 mmol) en 10 mi de agua destilada, bajo continua y vigorosa agitación. La dispersión resultante se calienta a 170° C, bajo presión autógena del sistema, durante 72 h. A continuación, Ia mezcla se enfría rápidamente a temperatura ambiente. El producto se filtra y se lava sucesivas veces con agua destilada y acetona. Example 1. Synthesis of AEFP-1 A solution of H 2 L (400 mg, 1 mmol) in 9 ml of isopropanol (Propan-2-ol, CH 3 CH (OH) CH 3 ) is mixed with another solution of Ca ( CH 3 CO 2 ) 2 -4 H 2 O (178 mg, 1 mmol) in 10 ml of distilled water, under continuous and vigorous stirring. The resulting dispersion is heated at 170 ° C, under autogenous system pressure, for 72 h. Then, the mixture is rapidly cooled to room temperature. The product is filtered and washed successively with distilled water and acetone.

En el Esquema 2 se representa el ácido carboxílico componente de AEPF-1 , denominado H2L de ahora en adelante. En AEPF-1 , el patrón de difracción de rayos X de [Ca(C25 5F9O6Hi5) 0.7C3H7O] tal y como se sintetiza, obtenido por el método de polvo utilizando una rendija de divergencia fija, con un equipo Bruker Advance equipado con anticátodo de cobre, se caracteriza por los valores angulares, los espaciados interplanares (d) correspondientes y las intensidades relativas (1/10) mostradas en Ia Tabla 2 y en Ia Figura 1. Se estima una discrepancia de 0.3°, en función del alineamiento del equipo, Ia cristalinidad de Ia muestra y grado de pureza. Scheme 2 depicts the carboxylic acid component of AEPF-1, referred to as H 2 L from now on. In AEPF-1, the X-ray diffraction pattern of [Ca (C 25 5 F 9 O 6 Hi 5 ) 0.7C 3 H 7 O] as synthesized, obtained by the powder method using a divergence slit Fixed, with a Bruker Advance equipment equipped with copper anti-cathode, it is characterized by the angular values, the corresponding inter-planar spacings (d) and the relative intensities (1/10) shown in Table 2 and in Figure 1. An estimated 0.3 ° discrepancy, depending on the alignment of the equipment, the crystallinity of the sample and degree of purity.

Por difracción de rayos X de monocristal se ha determinado Ia estructura del material AEPF-1. Pertenece al sistema cristalino monoclínico, grupo espacial P 2/n y los parámetros de celdilla son: a = 18,791(1 ) A, b = 7,5961 (5) A, c = 20,9987(5) A, β = 104,6(1 )°. The structure of the AEPF-1 material has been determined by monocrystalline X-ray diffraction. It belongs to the monoclinic crystalline system, spatial group P 2 / n and the cell parameters are: a = 18,791 (1) A, b = 7,5961 (5) A, c = 20,9987 (5) A, β = 104, 6 (1) °.

Siguiendo el mismo procedimiento, sustituyendo el propanol por butanol (C4H10O), tolueno (metilbenceno, CeH5CH3), hexano (CeHi4) heptano (C7Hi6), octano (C8Hi8) se obtiene el respectivo compuesto AEPF-1 isoestructural, [Ca(C25 5FgOeHi5) nA] (0 < n < 1 ), con una ligera variación en Ia intensidad relativa de los picos de difracción debido a Ia variación de composición según A utilizado. Ejemplo 2. Síntesis de AEFP-2 Mediante un proceso de secado, entre 100° C y 120° C y a vacío durante un tiempo de entre 10 y 20 h, del compuesto AEPF-1 se obtiene el compuesto AEPF-2. En el Esquema 2 se representa el ácido carboxílico componente de AEPF-2. Following the same procedure, replacing propanol with butanol (C4H10O), toluene (methylbenzene, CeH 5 CH 3 ), hexane (CeHi 4 ) heptane (C 7 Hi 6 ), octane (C 8 Hi 8 ), the respective AEPF compound is obtained -1 isostructural, [Ca (C 25 5 FgOeHi 5 ) nA] (0 <n <1), with a slight variation in the relative intensity of the diffraction peaks due to the variation in composition according to A used. Example 2. Synthesis of AEFP-2 Through a drying process, between 100 ° C and 120 ° C and under vacuum for a time between 10 and 20 h, the AEPF-1 compound is obtained. Scheme 2 depicts the carboxylic acid component of AEPF-2.

En AEPF-2, el patrón de difracción de rayos X de [Ca (C255F9θ6Hi5)] tal y como se sintetiza, obtenido por el método de polvo utilizando una rendija de divergencia fija, con un equipo Bruker Advance equipado con anticátodo de cobre, se caracteriza por los valores angulares, los espaciados interplanares (d) correspondientes y las intensidades relativas (1/10) mostradas en Ia Tabla 3 y Figura 2. Se estima una discrepancia de 0,3°, en función del alineamiento del equipo, Ia cristalinidad de Ia muestra y grado de pureza. Por difracción de rayos X de muestra policristalina se ha determinado el grupo espacial y parámetros de celdilla del material AEPF-2. Pertenece al sistema cristalino monoclínico, grupo espacial P 2/c y los parámetros de celdilla son: a = 24,614(1 ) A, b = 7,367(5) A, c = 31 ,519(5) A, β = 89,858(1 )°. Ejemplo 3. Síntesis de AEFP-3 In AEPF-2, the X-ray diffraction pattern of [Ca (C255F 9 θ6Hi 5 )] as synthesized, obtained by the powder method using a fixed divergence slit, with a Bruker Advance equipment equipped with an anti-cathode of copper, is characterized by angular values, corresponding inter-planar spacings (d) and relative intensities (1/10) shown in Table 3 and Figure 2. A discrepancy of 0.3 ° is estimated, depending on the alignment of the equipment , The crystallinity of the sample and degree of purity. The spatial group and cell parameters of the AEPF-2 material have been determined by X-ray diffraction of the polycrystalline sample. It belongs to the monoclinic crystalline system, spatial group P 2 / c and the cell parameters are: a = 24,614 (1) A, b = 7,367 (5) A, c = 31,519 (5) A, β = 89,858 (1) °. Example 3. Synthesis of AEFP-3

Se añade 101 mg de H2L (1 mmol) y 51 mg de Sr(CH3Cθ2)2 a una mezcla de 10 mi de H2O y 0,5 mi de piridina (C5H5N). La mezcla resultante se calienta a 180° C, bajo presión autógena del sistema, durante 48 h. A continuación, Ia mezcla se enfría rápidamente a temperatura ambiente. El producto se filtra y se lava sucesivas veces con agua destilada y acetona. El patrón de difracción del sólido obtenido blanco se muestra en Ia Figura 3. 101 mg of H 2 L (1 mmol) and 51 mg of Sr (CH 3 C 2) 2 are added to a mixture of 10 ml of H 2 O and 0.5 ml of pyridine (C 5 H 5 N). The resulting mixture is heated at 180 ° C, under autogenous system pressure, for 48 h. Then, the mixture is rapidly cooled to room temperature. The product is filtered and washed successively with distilled water and acetone. The diffraction pattern of the solid obtained white is shown in Figure 3.

En AEPF-3, el patrón de difracción de rayos X de [Sr(C25 5F9O6Hi5) nC5H5N] (0 < n < 1 ) tal y como se sintetiza, obtenido por el método de polvo utilizando una rendija de divergencia fija, con un equipo Bruker Advance equipado con anticátodo de cobre, se caracteriza por los valores angulares, los espaciados interplanares (d) correspondientes y las intensidades relativas (I/lo) mostradas en Ia Tabla 4 y Figura 3. Se estima una discrepancia de 0,3°, en función del alineamiento del equipo, Ia cristalinidad de Ia muestra y grado de pureza. In AEPF-3, the X-ray diffraction pattern of [Sr (C 25 5 F 9 O 6 Hi 5 ) nC 5 H 5 N] (0 <n <1) as synthesized, obtained by the method of powder using a Fixed divergence slit, with a Bruker Advance equipment equipped with copper anti-cathode, is characterized by the angular values, the corresponding inter-planar spacings (d) and the relative intensities (I / lo) shown in Table 4 and Figure 3. It is estimated a discrepancy of 0.3 °, depending on the alignment of the equipment, the crystallinity of the sample and degree of purity.

Por difracción de rayos X de monocristal se ha determinado Ia estructura de del material AEPF-3. Pertenecen al sistema cristalino monoclínico, grupo espacial P 2/n y los parámetros de celdilla son: a = 18,588(1 ) A, b = 7,8223(5) A, c = 21 ,399(1 ) A, β = 105,9(1 )°. The structure of the AEPF-3 material has been determined by single crystal X-ray diffraction. They belong to the monoclinic crystalline system, spatial group P 2 / n and the cell parameters are: a = 18,588 (1) A, b = 7,8223 (5) A, c = 21, 399 (1) A, β = 105, 9 (1) °.

Tabla 2 Table 2

10 10

15  fifteen

20 twenty

Figure imgf000017_0001
Figure imgf000017_0001

25  25

30 10 30 10

15  fifteen

20 twenty

Figure imgf000018_0001
Figure imgf000018_0001

25 25

30 Tabla 3 30 Table 3

10 10

15  fifteen

20 twenty

Figure imgf000019_0001
Figure imgf000019_0001

25  25

30 10 30 10

15  fifteen

20 twenty

Figure imgf000020_0001
Figure imgf000020_0001

25 25

30 Tabla 4 30 Table 4

10 10

15  fifteen

20 twenty

Figure imgf000021_0001
Figure imgf000021_0001

25  25

30 10 30 10

15fifteen

Figure imgf000022_0001
Figure imgf000022_0001

20 twenty

Ejemplo 4. Aplicación Example 4. Application

Hidrogenación de alquenos Hydrogenation of alkenes

La hidrogenación de estireno (vinilbenceno, CsH8) con H2 (Esquema 7) se consigue con selectividad del 100% y conversión de alqueno del 100% mediante el tratamiento de una mezcla de alqueno disuelto en tolueno con una presión de H2 de 5 atm, en presencia del catalizador del Ejemplo 1 en una relación catalizador/alqueno del 1% molar. La temperatura de reacción puede variar entre Ia ambiente y 100° C, consiguiéndose una velocidad óptima a 70° C. Hydrogenation of styrene (vinylbenzene, CsH 8 ) with H 2 (Scheme 7) is achieved with 100% selectivity and 100% alkene conversion by treating a mixture of alkene dissolved in toluene with a pressure of H 2 of 5 atm, in the presence of the catalyst of Example 1 in a catalyst / alkene ratio of 1 mol%. The reaction temperature can vary between room temperature and 100 ° C, achieving an optimum speed at 70 ° C.

Figure imgf000023_0001
Figure imgf000023_0001

Esquema 9  Scheme 9

Ejemplo 5. Aplicación  Example 5. Application

Hidrosililación de aldehidos Aldehyde Hydrosilylation

La hidrosililación de benzaldehído (CeH5CHO) con difenilsilano (Esquema 8) se consigue con selectividad del 100% y conversión de aldehido del 100% mediante el tratamiento de una mezcla de aldehido y silano en una relación de 1 :2 disueltos en tolueno seco en presencia del catalizador del Ejemplo 1 en una Hydrosilylation of benzaldehyde (CeH 5 CHO) with diphenylsilane (Scheme 8) is achieved with 100% selectivity and 100% aldehyde conversion by treating a mixture of aldehyde and silane in a ratio of 1: 2 dissolved in dry toluene in the presence of the catalyst of Example 1 in a

Figure imgf000023_0002
relación catalizador/aldehido del 10% molar.
Figure imgf000023_0002
10% molar catalyst / aldehyde ratio.

Esquema 10  Scheme 10

Ejemplo 6. Aplicación Hidrosililación de cetonas Example 6. Hydrosilylation application of ketones

La hidrosililación de acetofenona con difenilsilano (Esquema 9) se consigue selectividad del 100% y conversión de acetofenona mayor al 70% mediante el tratamiento de una mezcla de cetona y silano en una relación de 1 :2 disueltos en tolueno seco a 90° C, en presencia del catalizador del Ejemplo 1 en una relación catalizador/acetona del 10% molar. Hydrosilylation of acetophenone with diphenylsilane (Scheme 9) achieves 100% selectivity and conversion of acetophenone greater than 70% by treating a mixture of ketone and silane in a ratio of 1: 2 dissolved in dry toluene at 90 ° C, in the presence of the catalyst of Example 1 in a catalyst / acetone ratio of 10 mol%.

Figure imgf000024_0001
Figure imgf000024_0001

Esquema 11  Scheme 11

Ejemplo 7. Aplicación Example 7. Application

Hidrosililación de alquenos Alkene Hydrosilylation

La hidrosililación de estireno con difenilsilano (Esquema 10) se consigue selectividad del 100% al producto lineal y conversión de alqueno del 100% mediante el tratamiento de una mezcla de alqueno y silano en una relación de 3:1 disueltos en tolueno seco a 90° C, en presencia del catalizador del Ejemplo 1 en una relación catalizador/alqueno del 10% molar. Hydrosilylation of styrene with diphenylsilane (Scheme 10) achieves 100% selectivity to the linear product and conversion of 100% alkene by treating a mixture of alkene and silane in a 3: 1 ratio dissolved in dry toluene at 90 ° C, in the presence of the catalyst of Example 1 in a catalyst / alkene ratio of 10 mol%.

Figure imgf000025_0001
Figure imgf000025_0001

Esquema 12  Scheme 12

Ejemplo 8. Aplicación  Example 8. Application

Hidroaminación intermolecular de alquenos. Intermolecular hydroamination of alkenes.

Figure imgf000025_0002
Figure imgf000025_0002

Esquema 13 Scheme 13

La hidroaminación intermolecular de 1-amino-2,2-dimetilhex-5-eno (Esquema 13) se consigue en 2 horas, con 100% de selectividad, en benceno a 80 0C, en presencia del catalizador del Ejemplo 1 en una relación de catalizador/aminoalqueno del 10% molar. The intermolecular hydroamination of 1-amino-2,2-dimethylhex-5-ene (Scheme 13) is achieved in 2 hours, with 100% selectivity, in benzene at 80 0 C, in the presence of the catalyst of Example 1 in a ratio of 10% molar catalyst / aminoalkene.

Claims

REIVINDICACIONES 1. Material órgano-inorgánico de fórmula: 1. Organ-inorganic material of formula: [M (HOOC-R-COOH)x (OOC-R-COO)y (H2O)2 nA] [M (HOOC-R-COOH) x (OOC-R-COO) and (H 2 O) 2 nA] donde:  where: M es un catión alcalinotérreo,  M is an alkaline earth cation, - A es una molécula huésped, que comprende un solvente seleccionado de Ia lista que comprende etanol, propanol, butanol, tolueno, ciclohexano, hexano, heptano, octano, piridina y cualquiera de sus combinaciones,  - A is a host molecule, which comprises a solvent selected from the list comprising ethanol, propanol, butanol, toluene, cyclohexane, hexane, heptane, octane, pyridine and any combination thereof, R es un grupo aromático seleccionado entre fenilo, naftilo o difenilo, que está ramificado o no con otros grupos,  R is an aromatic group selected from phenyl, naphthyl or diphenyl, which is branched or not with other groups, - x representa un valor menor o igual a 4,  - x represents a value less than or equal to 4, - y representa un valor de entre 0,5 y 2,  - and represents a value between 0.5 and 2, - z representa un valor de entre O y 4 y  - z represents a value between O and 4 and n representa un valor de entre O y 4.  n represents a value between O and 4. 2. Material según Ia reivindicación 1 , donde M se selecciona entre Mg, Ca, Sr o Ba. 2. Material according to claim 1, wherein M is selected from Mg, Ca, Sr or Ba. 3. Material según cualquiera de las reivindicaciones 1 ó 2, donde Ia relación x:y:z es 0,5:1 :1 y n representa un valor de entre O y 2. 3. Material according to any of claims 1 or 2, wherein the ratio x: y: z is 0.5: 1: 1 and n represents a value between O and 2. 4. Material según cualquiera de las reivindicaciones 1 a 3, donde R se representa por Ia fórmula general Ri-C(R2)2-Ri, donde Ri es un grupo aromático seleccionado de entre fenilo, naftilo o difenilo y R2 es un grupo seleccionado de entre metilo, etilo, isopropilo, terbutilo o CF3. 4. Material according to any of claims 1 to 3, wherein R is represented by the general formula Ri-C (R 2 ) 2 -Ri, where Ri is an aromatic group selected from phenyl, naphthyl or diphenyl and R 2 is a group selected from methyl, ethyl, isopropyl, terbutyl or CF 3 . 5. Material según Ia reivindicación 4, donde Ri es un grupo fenilo y R2 es un grupo CF3, y se representa por:
Figure imgf000027_0001
5. Material according to claim 4, wherein Ri is a phenyl group and R 2 is a CF 3 group, and is represented by:
Figure imgf000027_0001
6. Material según cualquiera de las reivindicaciones 1 a 5, de fórmula: 6. Material according to any of claims 1 to 5, of formula: [Ca (CI7HI0O4F6)X (Ci7H8O4F6)y (H2O)z-nA] donde: [Ca (CI 7 HI 0 O 4 F 6 ) X (Ci 7 H 8 O 4 F6) and (H 2 O) z -nA] where: - x representa un valor de 0,5,  - x represents a value of 0.5, - y representa un valor de 1 ,  - and represents a value of 1, - z representa un valor de 1 ,  - z represents a value of 1, - n representa un valor de 0,7 y  - n represents a value of 0.7 and - A se selecciona de entre etanol, propanol, butanol, tolueno, ciclohexano, hexano, heptano, octano o cualquiera de sus combinaciones.  - A is selected from ethanol, propanol, butanol, toluene, cyclohexane, hexane, heptane, octane or any combination thereof. 7. Material según cualquiera de las reivindicaciones 1 a 6, de fórmula: 7. Material according to any of claims 1 to 6, of formula: [Ca (Ci7HioO4F6)x (Ci7H8O4F6)y (H2O)Z] [Ca (Ci 7 HioO 4 F 6 ) x (Ci 7 H 8 O 4 F 6 ) and (H 2 O) Z ] donde: where: - x representa un valor de 0,5,  - x represents a value of 0.5, - y representa un valor de 1 ,  - and represents a value of 1, - z representa un valor de 1 ,  - z represents a value of 1, n representa un valor de 0.  n represents a value of 0. 8. Material según cualquiera de las reivindicaciones 1 a 7, de fórmula: 8. Material according to any of claims 1 to 7, of formula: [Sr (Ci7H10O4F6)X (Ci7H8O4F6)y (H2O^nC5H5N] [Sr (Ci 7 H 10 O 4 F 6 ) X (Ci 7 H 8 O 4 F 6 ) and (H 2 O ^ nC 5 H 5 N] donde: where: - x representa un valor de 0,5,  - x represents a value of 0.5, - y representa un valor de 1 , - z representa un valor de 1 , - and represents a value of 1, - z represents a value of 1, - n representa un valor de entre 0 < n < 1.  - n represents a value between 0 <n <1. 9. Procedimiento de preparación del material según cualquiera de las  9. Procedure for preparing the material according to any of the reivindicaciones 1 a 8, que comprende:  claims 1 to 8, comprising: a) preparación de una mezcla de reacción que comprende:  a) preparation of a reaction mixture comprising: - un catión alcalinotérreo M,  - an alkaline earth cation M, - un ácido dicarboxílico HOOC-Ri-C(R2)2-Ri-COOH, donde- a HOOC-Ri-C (R 2 ) 2 -Ri-COOH dicarboxylic acid, where Ri es un grupo aromático seleccionado de entre fenilo, naftilo o difenilo y R2 es un grupo seleccionado de entre metilo, etilo, isopropilo, terbutilo o CF3, Ri is an aromatic group selected from phenyl, naphthyl or biphenyl , and R2 is a group selected from methyl, ethyl, isopropyl, tert - butyl or CF 3, - una molécula huésped A, que comprende un solvente seleccionado de Ia lista que comprende etanol, propanol, butanol, tolueno, ciclohexano, hexano, heptano, octano, piridina y cualquiera de sus combinaciones y  - a host molecule A, comprising a solvent selected from the list comprising ethanol, propanol, butanol, toluene, cyclohexane, hexane, heptane, octane, pyridine and any combination thereof and - agua;  - Water; b) tratamiento térmico de Ia mezcla de reacción de Ia etapa (a) a una temperatura de entre 80° C y 220° C hasta conseguir su cristalización.  b) heat treatment of the reaction mixture of stage (a) at a temperature between 80 ° C and 220 ° C until its crystallization is achieved. 10. Procedimiento según Ia reivindicación 9, donde en el ácido dicarboxílico10. Process according to claim 9, wherein in the dicarboxylic acid HOOC-Ri-C(R2)2-Ri-COOH, Ri es un grupo fenilo y R2 es un grupo CF3. HOOC-Ri-C (R 2 ) 2-Ri-COOH, Ri is a phenyl group and R 2 is a CF 3 group. 11. Procedimiento según cualquiera de las reivindicaciones 9 ó 10, donde el ácido dicarboxílico de Ia mezcla de reacción de Ia etapa (a) está en forma de sal. 11. Method according to any of claims 9 or 10, wherein the dicarboxylic acid of the reaction mixture of step (a) is in the form of salt. 12. Procedimiento según cualquiera de las reivindicaciones 9 a 11 , donde Ia mezcla de reacción tiene una composición, en términos de relaciones molares, comprendida entre los intervalos: 12. Method according to any of claims 9 to 11, wherein the reaction mixture has a composition, in terms of molar ratios, comprised between the intervals: - M/ácido dicarboxílico = 0,25-1  - M / dicarboxylic acid = 0.25-1 - H2O/S = 4,5-10,3 - H 2 O / S = 4.5-10.3 - H2O/M = 300-800 - H 2 O / M = 300-800 13. Procedimiento según cualquiera de las reivindicaciones 9 a 12, donde el tratamiento térmico al que se somete Ia mezcla de reacción en Ia etapa (b) se realiza a una temperatura de entre 130° C y 200° C. 13. Method according to any of claims 9 to 12, wherein the heat treatment to which the reaction mixture is subjected in stage (b) is carried out at a temperature between 130 ° C and 200 ° C. 14. Procedimiento según cualquiera de las reivindicaciones 9 a 13, que además comprende: 14. Method according to any of claims 9 to 13, further comprising: a) separación, lavado y tratamiento térmico del producto cristalino obtenido en Ia etapa (b) a una temperatura de secado de entre 40° C y 150° C.  a) separation, washing and heat treatment of the crystalline product obtained in stage (b) at a drying temperature between 40 ° C and 150 ° C. 15. Procedimiento según Ia reivindicación 14, donde Ia separación, lavado y tratamiento térmico del producto cristalino obtenido en Ia etapa (b) se lleva a cabo a una temperatura de secado de entre 100° C y 120° C y a vacío durante un tiempo de entre 10 y 20 h. 15. Method according to claim 14, wherein the separation, washing and heat treatment of the crystalline product obtained in step (b) is carried out at a drying temperature of between 100 ° C and 120 ° C and under vacuum for a period of between 10 and 20 h. 16. Uso del material según cualquiera de las reivindicaciones 1 a 8 como catalizador en un proceso de conversión de compuestos. 16. Use of the material according to any of claims 1 to 8 as a catalyst in a compound conversion process. 17. Uso del material según Ia reivindicación 16, donde el proceso de conversión de compuestos es una hidrogenación de alquenos usando como agente reductor H2. 17. Use of the material according to claim 16, wherein the compound conversion process is a hydrogenation of alkenes using H 2 as reducing agent. 18. Uso del material según Ia reivindicación 16, donde el proceso de conversión de compuestos es una hidroformilación de alquenos. 18. Use of the material according to claim 16, wherein the process of conversion of compounds is a hydroformylation of alkenes. 19. Uso del material según Ia reivindicación 16, donde el proceso de conversión de compuestos es una hidrosililación de aldehidos usando como reactivo un compuesto orgánico derivado del silano. 19. Use of the material according to claim 16, wherein the process of conversion of compounds is a hydrosilylation of aldehydes using as reagent an organic compound derived from silane. 20. Uso del material según Ia reivindicación 16, donde el proceso de conversión de compuestos es una hidrosililación de cetonas usando como reactivo un compuesto orgánico derivado del silano. 20. Use of the material according to claim 16, wherein the process of conversion of compounds is a hydrosilylation of ketones using as reagent an organic compound derived from silane. 21. Uso del material según Ia reivindicación 16, donde el proceso de conversión de compuestos es una hidrosililación de alquenos usando como reactivo un compuesto orgánico derivado del silano. 21. Use of the material according to claim 16, wherein the process of conversion of compounds is a hydrosilylation of alkenes using as reagent an organic compound derived from silane. 22. Uso del material según Ia reivindicación 16, donde el proceso de conversión de compuestos es una hidroaminación intermolecular de aminoalquenos lineales. 22. Use of the material according to claim 16, wherein the compound conversion process is an intermolecular hydroamination of linear aminoalkenes. 23. Uso del material según cualquiera de las reivindicaciones 1 a 8 como absorbente de compuestos. 23. Use of the material according to any of claims 1 to 8 as a compound absorbent. 24. Uso del material según cualquiera de las reivindicaciones 1 a 8 como tamiz molecular. 24. Use of the material according to any of claims 1 to 8 as a molecular sieve. 25. Uso del material según cualquiera de las reivindicaciones 1 a 8 como sistema de liberación controlada de fármacos. 25. Use of the material according to any of claims 1 to 8 as a controlled drug delivery system.
PCT/ES2010/070439 2009-06-30 2010-06-29 Organic/inorganic microporous crystalline material based on alkaline-earth cations, preparation method and uses Ceased WO2011000989A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ESP200930393 2009-06-30
ES200930393A ES2351494B1 (en) 2009-06-30 2009-06-30 ORGANIC-INORGANIC MICROPOROUS CRYSTAL MATERIAL BASED ON ALKALINERERAL CATIONS, PREPARATION PROCEDURE AND USES

Publications (1)

Publication Number Publication Date
WO2011000989A1 true WO2011000989A1 (en) 2011-01-06

Family

ID=43410518

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2010/070439 Ceased WO2011000989A1 (en) 2009-06-30 2010-06-29 Organic/inorganic microporous crystalline material based on alkaline-earth cations, preparation method and uses

Country Status (2)

Country Link
ES (1) ES2351494B1 (en)
WO (1) WO2011000989A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140271874A1 (en) * 2013-03-15 2014-09-18 Synbias Pharma Ltd. Stable crystalline monohydrate of epirubicin hydrochloride and method of production

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
COLLEEN A. ET AL.: "Novthe Metal-Organic Frameworks Derived from Group II Metal Cations and Aryldicarboxylate Anionic Ligands", CRYST. GROWTH DES., vol. 8, no. 3, 5 February 2008 (2008-02-05), pages 811 - 922 *
DAVIES, R.P. ET AL.: "Framework materials assembled from magnesium carboxylate building units", DALTON TRANSACTIONS, 18 May 2007 (2007-05-18), pages 2528 - 2535 *
DINCA, M. ET AL.: "Strong H2 Binding and Selective Gas Adsorption within the Microporous Coordination Solid Mg3(02C-ClOH6-C02)3", J. AM.SOC., vol. 127, 6 September 2005 (2005-09-06), pages 9376 - 9377 *
VOLKRINGER, C. ET AL.: "Hydrothermal Crystallization of Three Calcium-Based Hybrid Solids with 2,6-Napthalene- or 4,4'Biphenyl- Dicarboxylates", CRYST. GROWTH DES., vol. 8, no. 2, 15 December 2007 (2007-12-15), pages 685 - 689 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140271874A1 (en) * 2013-03-15 2014-09-18 Synbias Pharma Ltd. Stable crystalline monohydrate of epirubicin hydrochloride and method of production

Also Published As

Publication number Publication date
ES2351494A1 (en) 2011-02-07
ES2351494B1 (en) 2011-11-28

Similar Documents

Publication Publication Date Title
KR102056816B1 (en) Novel metal-organic framework having porous structure comprising Zirconium cluster secondary building units and multitopic organic linkers
CA2440114C (en) Organometallic framework materials and process for preparing them
RU2561603C2 (en) Organometallic skeleton materials based on 2,5-furandicarboxylic or 2,5-thiophenecarboxylic acid
Corma et al. Engineering metal organic frameworks for heterogeneous catalysis
Yang et al. Synthesis, characterization, and catalytic activity of sulfonic acid-functionalized periodic mesoporous organosilicas
KR101004304B1 (en) Molded bodies containing metal-organic frameworks
US9777029B2 (en) Process for obtaining metal-organic materials with structure type MIL-101 (Cr) and MIL-101-Cr-MX+
KR20150007484A (en) Novel Zn-MOF compounds, and carbon dioxide sorption and heterogeneous catalysts for transesterification comprising the same
JP7482786B2 (en) Synthesis of zinc MOF materials
Rasal et al. Solventless synthesis of cyclic carbonates by direct utilization of CO2 using nanocrystalline lithium promoted magnesia
KR100525208B1 (en) The preparation method of nanoporous VSB-5 molecular sieve
CN112280052A (en) Hierarchical pore ZIF-8 material and preparation method and application thereof
Mutiah et al. Immobilisation of L-proline onto mixed-linker zirconium MOFs for heterogeneous catalysis of the aldol reaction
Ibrahim et al. Applications of nanostructure phosphomolybdic acid/strontium MOF for removal of Rhodamine B and synthesis of pharmaceutically significant 14-Aryl-14-alkyl-14-H-dibenzoxanthene and 7-hydroxy-4-methyl coumarin
Esquivel et al. Thermal behaviour, sulfonation and catalytic activity of phenylene-bridged periodic mesoporous organosilicas
JP4459535B2 (en) Method for immobilizing homogeneous catalyst and catalyst material
WO2011000989A1 (en) Organic/inorganic microporous crystalline material based on alkaline-earth cations, preparation method and uses
KR20240026218A (en) Method for preparing metal-organic frameworks using precursors and crystallization aids
Pal et al. Highly ordered Zn-doped mesoporous silica: An efficient catalyst for transesterification reaction
KR100525209B1 (en) Metal-incorporated nanoporous materials, Metal-VSB-5 molecular sieve and their preparation methods
KR101568965B1 (en) Metal-organic frameworks
Dadvar et al. Application of sodium titanate nanotubes doped with vanadium (VNaTNT) as a heterogeneous catalyst for oxidation of sulfides at room temperature
Salavati-Niasari et al. Host (nanopores of zeolite Y)-guest (oxovanadium (IV) tetradentate schiff-base complexes) nanocomposite materials: synthesis, characterization and liquid phase hydroxylation of phenol with hydrogen peroxide
RU2762171C2 (en) Method for producing a moulded article containing zinc and a titanium-containing zeolite
Reshma et al. Boehmite—An Efficient and Recyclable Acid-Base Bifunctional Catalyst for Aldol Condensation Reaction

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10793641

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10793641

Country of ref document: EP

Kind code of ref document: A1